Oxford Science Enterprises

Portfolio Co Investors 2026 for Oxford Science Enterprises: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Oxford Science Enterprises accounts for 17 tracked companies with verified cap-table data, 17 of which disclose round sizes totalling $3.1B. The median disclosed raise is $100M, and the largest is Oxford Ionics at $1.1B, ahead of AGTC ($290M) and Beacon Therapeutics ($290M).

The names that recur most often on these co-invested cap tables are Oxford Science Enterprises (17 companies), Lansdowne Partners (3 companies), Syncona (3 companies), Parkwalk Advisors (3 companies), Oxford Sciences Innovation (3 companies), Braavos Investment Advisers (2 companies). By latest disclosed round, the market skews Series B (10), Series A (5), Series C (2).

Best funded Oxford Science Enterprises companies

  1. Oxford Ionics — $1.1B (latest: Series A)
  2. AGTC — $290M (latest: Series B)
  3. Beacon Therapeutics — $290M (latest: Series B)
  4. Quantum Motion — $251M (latest: Series C)
  5. Osler Diagnostics — $170M (latest: Series C)
  6. OMass Technologies — $160M (latest: Series B)
  7. Grey Wolf Therapeutics — $131M (latest: Series B)
  8. ONI — $100M (latest: Series B)
  9. Amber Therapeutics — $100M (latest: Series A)
  10. MoA Technology — $100M (latest: Series B)
  11. Alloyed — $99M (latest: Series B)
  12. Sitryx Therapeutics — $75M (latest: Series B)
  13. PQShield — $65M (latest: Series B)
  14. Wild Bioscience — $60M (latest: Series A)
  15. Mind Foundry — $44M (latest: Series B)

Oxford Science Enterprises — related firms and companies (56)

Oxford Science Enterprises alternatives · All research reports